Your browser is no longer supported. Please, upgrade your browser.
NVIV InVivo Therapeutics Holdings Corp. daily Stock Chart
InVivo Therapeutics Holdings Corp.
Index- P/E- EPS (ttm)-11.65 Insider Own12.35% Shs Outstand21.17M Perf Week0.69%
Market Cap12.04M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float19.62M Perf Month3.38%
Income-10.30M PEG- EPS next Q- Inst Own3.80% Short Float1.88% Perf Quarter-57.68%
Sales- P/S- EPS this Y74.90% Inst Trans-9.16% Short Ratio0.42 Perf Half Y-61.58%
Book/sh1.60 P/B0.36 EPS next Y- ROA-91.10% Target Price- Perf Year-85.58%
Cash/sh0.38 P/C1.52 EPS next 5Y- ROE-124.40% 52W Range0.50 - 11.98 Perf YTD-91.34%
Dividend- P/FCF- EPS past 5Y43.70% ROI- 52W High-95.16% Beta1.79
Dividend %- Quick Ratio4.40 Sales past 5Y- Gross Margin- 52W Low16.58% ATR0.05
Employees6 Current Ratio4.40 Sales Q/Q- Oper. Margin- RSI (14)29.69 Volatility5.64% 5.95%
OptionableNo Debt/Eq0.00 EPS Q/Q94.60% Profit Margin- Rel Volume1.40 Prev Close0.58
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume883.00K Price0.58
Recom- SMA204.31% SMA50-39.97% SMA200-66.78% Volume160,697 Change-0.68%
Jul-31-17Downgrade Raymond James Outperform → Mkt Perform
May-05-17Downgrade Raymond James Strong Buy → Outperform
Jul-21-16Initiated Ladenburg Thalmann Buy
Jul-07-16Initiated Raymond James Strong Buy $13
Oct-26-20 04:15PM  
Oct-22-20 09:15AM  
Sep-11-20 08:30AM  
Apr-17-20 12:19PM  
Apr-15-20 07:30PM  
Mar-11-20 04:27PM  
Mar-06-20 09:15AM  
Feb-03-20 04:30PM  
Nov-22-19 04:30PM  
Nov-21-19 08:00AM  
Nov-18-19 08:15AM  
Nov-12-19 08:00AM  
Oct-29-19 10:51AM  
Oct-22-19 08:00AM  
Jul-16-19 08:00AM  
Jul-12-19 08:00AM  
Jun-14-19 08:00AM  
May-29-19 02:54PM  
Apr-17-19 08:00AM  
Apr-01-19 08:15AM  
Jan-14-19 08:00AM  
Nov-29-18 08:00AM  
Nov-19-18 09:00AM  
Nov-08-18 06:55PM  
Oct-02-18 08:00AM  
Oct-01-18 08:00AM  
Sep-28-18 08:05AM  
Aug-28-18 08:00AM  
Aug-07-18 07:42PM  
Jun-25-18 04:05PM  
Jun-21-18 09:00AM  
May-24-18 10:35AM  
May-07-18 06:44PM  
Apr-18-18 08:20AM  
Apr-09-18 08:00AM  
Mar-19-18 08:00AM  
Mar-12-18 08:35AM  
Mar-09-18 10:34AM  
Mar-08-18 08:00AM  
Feb-05-18 08:00AM  
Jan-29-18 07:00AM  
Jan-26-18 08:00AM  
Jan-03-18 08:00AM  
Dec-18-17 08:00AM  
Nov-06-17 08:00AM  
Oct-30-17 06:03PM  
Oct-11-17 10:14AM  
Oct-10-17 08:00AM  
Sep-20-17 08:00AM  
Sep-05-17 08:00AM  
Aug-29-17 05:59PM  
Aug-28-17 04:30PM  
Aug-10-17 09:00AM  
Aug-09-17 11:37PM  
Aug-08-17 06:00PM  
Aug-01-17 08:00AM  
Jul-31-17 12:46PM  
Jul-12-17 08:00AM  
Jul-11-17 08:00AM  
Jul-10-17 08:00AM  
Jun-29-17 08:00AM  
Jun-28-17 09:45AM  
Jun-27-17 08:00AM  
Jun-20-17 08:00AM  
Jun-12-17 08:00AM  
Jun-01-17 08:00AM  
May-30-17 08:00AM  
May-09-17 08:00AM  
May-08-17 08:00AM  
May-05-17 05:03AM  
May-04-17 04:36PM  
Apr-20-17 08:00AM  
Apr-10-17 08:00AM  
Apr-05-17 08:00AM  
Mar-31-17 04:04PM  
Mar-30-17 08:00AM  
Mar-29-17 08:00AM  
Mar-28-17 08:00AM  
Mar-27-17 08:00AM  
Mar-23-17 08:00AM  
Mar-21-17 08:00AM  
Mar-20-17 08:00AM  
Mar-16-17 01:04PM  
Mar-15-17 08:00AM  
Mar-10-17 04:46PM  
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. The company is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for the implantation at the site of injury within a spinal cord. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.